AllPennyStocks.com MannKind Expands Into Weight Loss With Rose Pharma Deal – Here’s What Investors Are Watching
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

MannKind Expands Into Weight Loss With Rose Pharma Deal – Here’s What Investors Are Watching

MannKind and Rose Pharma are partnering to develop an inhaled weight-loss treatment using the Technosphere dry-powder inhalation technology.

Other Penny Stock Movers

Digestive Health Expansion Sends This Microcap Soaring
Utah Copper Explorer Jumps 19% on Surface Assays
Indonesian Gold Developer Jumps 27% as Ministry Moves File to Final Approval
Most Popular
{{ index + 1 }}
AllPennyStocks.com Favorites


Back to Top